CSL is a leading global biotechnology company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies.
Today, CSL – including our businesses, CSL Behring, CSL Seqirus, CSL Plasma and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 32,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.
See our community guidelines: https://bit.ly/3Bs17Ra
|
|
|
201-500 employees
View all CSL Behring employees
|
|
Biotechnology
|
|
45 Poplar Rd, Melbourne, VIC 3052, AU
|
|
1916
|
|
Biotechnology, Complex Biologicals, Plasma And Plasma Derived Therapeutics, Vaccines
|
Sabir Momluk is the CEO of CSL. To contact Sabir Momluk email at [email protected] or [email protected].
The decision makers in CSL are Carlos Valenzuela, Dexter Rodriguez, Dominic Amuzu, etc. Click to Find CSL decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.